期刊文献+

肿瘤特异增殖型腺病毒穿梭质粒pAd-delE1b55kD的构建 被引量:2

Construction of replication-competent adenovirus shuttle plasmids pAd-delE1b55kD
下载PDF
导出
摘要 目的:构建一种对肿瘤细胞有特异靶向性的高效载体-肿瘤特异增殖型腺病毒的穿梭质粒pAd-delE1b55kD。方法:利用二步法PCR等基因重组技术,将质粒pXC1编码E1B-55kD蛋白的基因区域缺失,并保留一个BglII酶切位点,以便插入外源性基因;利用凝胶图像分析和基因测序验证所构建质粒的正确性。结果:质粒pXC1的基因序列中,编码E1B-55kD蛋白的基因区中的2279~3326bp区域缺失,该区域上游的序列中第2024位碱基C点突变为T,第2252位碱基C点突变为T及第2261位碱基G点突变为T,从而在该区域上游插入了终止密码子TGA、TAG和TAA。在终止密码子下游,保留了一个BglII酶切位点。结论:成功构建了肿瘤特异增殖型腺病毒穿梭质粒载体pAd-delE1b55kD,为肿瘤的基因治疗提供了一种对肿瘤细胞有特异靶向性的高效载体的穿梭质粒。 Objective: To construct a replication-competent adenovims shuttle plasmids named pAd-delElb55kD, which can transfectthe cell of tumor targeted. Methods: delete the EIB55 region of pXCI and retain a site for Bgl II by such technique of gene recombinationas nested PCR; verify the correctness of pAd-delElb55kD by gel image analysis and sequencing the gene order. Resu/ts: The 2279-3326region of EIB in pXCI was deleted. The 2024 basic radical C was mutated to T, the 2252 basic radical C to T and the 2261 basic radical Gto T. Stop codon TGA ,TAG and TAA were inserted. A site for Bgl Ⅱwas retained in downstream of the stop codon. Conclusion: Thereplication-competent adenovims shuttle plasmids named pAd-deLE1b55kD is constructed, which provided a carrier for the gene therapyof tumor targeted.
出处 《重庆医科大学学报》 CAS CSCD 2006年第3期314-317,共4页 Journal of Chongqing Medical University
基金 重庆市自然科学基金项目(编号:2005BB5225)
关键词 肿瘤 基因治疗 肿瘤特异增殖型腺病毒 穿梭质粒 tumor gene therapy replication-competent adenovirus shuttle plasmids
  • 相关文献

参考文献6

  • 1Bischof JR,Kirn DH,Williams A,et al.An adenovirus mutant that replicates selectively in p53-deficient human tumor cells[J].Science,1996;274:373-376.
  • 2Heise CC,Williams AM,Xue S,et al.Intravenous administration of ONYX-015,a selectively replicating adenovirus,induces antitumoral efficacy[J].Cancer Res,1999;59(11):2623-2628.
  • 3Goodrum FD,Ornelles DA.The early region IB 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle[J].J Virol,1997;71:548-561.
  • 4Fhuri FR,Nemunaitis J,Ganly I,et al.A controlled trial of intratumral ONYX-015,a selectively-replicating adenovirus,in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer[J].Nature Medicine,2000;6:879-885.
  • 5Nemunaitis J,Ganly I,Khuri F,et al.Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015,an E1B55kD Gene-deleted Adenovirus,in Patients with Advanced Head and Neck Cancer:A Phase Ⅱ Trial[J].Cancer Res,2000;60:6359-6366.
  • 6ZILAIZHANG,WEIGUOZOU,CHUNXIALUO,BINGHUALI,JINHUIWANG,LANYINGSUN,QIJUNQIAN,XINYUANLIU.An armed oncolytic adenovirus system,ZD55-gene,demonstrating potent antitumoral efficacy[J].Cell Research,2003,13(6):481-489. 被引量:46

二级参考文献10

  • 1Khuri FR,Nemunaitis J,Ganly I,et al.A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer[].Nature Medicine.2000
  • 2Khuri FR,Nemunaitis J,Ganly I,et al.A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer[].Nature Medicine.2000
  • 3Heise C,Kim DH.Replication-selective adenoviruses as onco lytic agents[].The Journal of Clinical Investigation.2000
  • 4Heise CC,Williams AM,Xue S,Propst M,Kirn DH.Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy[].Cancer Research.1999
  • 5Goodrum FD,Ornelles DA.The early region1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle[].Journal of Virology.1997
  • 6Wildner O,Morris JC.The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus tk: assessment of antitumor efficacy and toxicity[].Cancer Research.2000
  • 7Hawkins LK,Johnson L,Bauzon M,et al.Gene delivery from the E3 region of replicating human adenovirus: Evaluation of the 6. 7K/gp 19K region[].Gene Therapy.2001
  • 8Gomez-Navarro J,Curiel DT.Conditionally replicative adeno viral vectors for cancer gene therapy[].The Lancet Oncology.2000
  • 9Shinoura N,Yoshida Y,Tsunoda R,et al.Highly augmented cytopathic effect of a fiber-mutant E1 B-defective adenovirus for gene therapy of gliomas[].Cancer Research.1999
  • 10Suzuki K,Fueyo J,Krasnykh V,Reynolds PN,Curiel DT,Alemany R.A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency[].Clinical Cancer Research.2001

共引文献45

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部